Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Pediatric Blood & Cancer|May 28, 2011
Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonusMichael R Pranzatelli, Elizabeth D Tate, Shalini Shenoy, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 11, 2013
Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassayMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, et al.Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|December 3, 2004
Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndromeElizabeth D Tate, Tyler J Allison, Michael R Pranzatelli, et al.Pediatric Neurology|September 11, 2018
Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus SyndromeMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, et al.Journal of Clinical Immunology|October 20, 2009
Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonusMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.Journal of the Neurological Sciences|February 6, 2013
Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disordersMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, et al.Cytokine|June 15, 2013
CCR7 signaling in pediatric opsoclonus-myoclonus: upregulated serum CCL21 expression is steroid-responsiveMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, et al.Cytokine|January 8, 2011
Chemokine/cytokine profiling after rituximab: reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMSMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.Journal of Neuroimmunology|December 18, 2013
CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disordersMichael R Pranzatelli, Elizabeth D Tate, Nathan R McGee, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIGMichael R Pranzatelli, Elizabeth D Tate, Marcel Kinsbourne, et al.Pageof 4